[HTML][HTML] The early decline of α-fetoprotein and des-γ-carboxy prothrombin predicts the response of hepatic arterial infusion chemotherapy in hepatocellular carcinoma …
S Yamamoto, H Onishi, A Takaki, A Oyama… - Gastrointestinal …, 2020 - karger.com
Introduction: Molecular targeting drugs are recommended as second-line treatment for
intrahepatic advanced hepatocellular carcinoma (HCC). However, in Asia, hepatic arterial …
intrahepatic advanced hepatocellular carcinoma (HCC). However, in Asia, hepatic arterial …
The Early Decline of α-Fetoprotein and Des-γ-Carboxy Prothrombin Predicts the Response of Hepatic Arterial Infusion Chemotherapy in Hepatocellular Carcinoma …
S Yamamoto, H Onishi, A Takaki, A Oyama… - Gastrointestinal …, 2020 - europepmc.org
Results The number of patients showing a complete response (CR), a partial response (PR),
stable disease (SD), and progressive disease (PD) was 0 (0%), 20 (43%), 18 (38%), and 9 …
stable disease (SD), and progressive disease (PD) was 0 (0%), 20 (43%), 18 (38%), and 9 …
The Early Decline of α-Fetoprotein and Des-γ-Carboxy Prothrombin Predicts the Response of Hepatic Arterial Infusion Chemotherapy in Hepatocellular Carcinoma …
S Yamamoto, H Onishi, A Takaki, A Oyama… - Gastrointestinal …, 2020 - karger.com
Introduction: Molecular targeting drugs are recommended as second-line treatment for
intrahepatic advanced hepatocellular carcinoma (HCC). However, in Asia, hepatic arterial …
intrahepatic advanced hepatocellular carcinoma (HCC). However, in Asia, hepatic arterial …
The Early Decline of alpha-Fetoprotein and Des-gamma-Carboxy Prothrombin Predicts the Response of Hepatic Arterial Infusion Chemotherapy in Hepatocellular …
S Yamamoto, H Onishi, A Takaki, A Oyama… - Gastrointestinal …, 2020 - cir.nii.ac.jp
抄録 Introduction: Molecular targeting drugs are recommended as second-line treatment for
intrahepatic advanced hepatocellular carcinoma (HCC). However, in Asia, hepatic arterial …
intrahepatic advanced hepatocellular carcinoma (HCC). However, in Asia, hepatic arterial …
The Early Decline of α-Fetoprotein and Des-γ-Carboxy Prothrombin Predicts the Response of Hepatic Arterial Infusion Chemotherapy in Hepatocellular Carcinoma …
S Yamamoto, H Onishi, A Takaki… - Gastrointestinal …, 2020 - pubmed.ncbi.nlm.nih.gov
Introduction Molecular targeting drugs are recommended as second-line treatment for
intrahepatic advanced hepatocellular carcinoma (HCC). However, in Asia, hepatic arterial …
intrahepatic advanced hepatocellular carcinoma (HCC). However, in Asia, hepatic arterial …
The Early Decline of α-Fetoprotein and Des-γ-Carboxy Prothrombin Predicts the Response of Hepatic Arterial Infusion Chemotherapy in Hepatocellular Carcinoma …
S Yamamoto, H Onishi, A Takaki… - Gastrointestinal …, 2020 - search.ebscohost.com
Introduction: Molecular targeting drugs are recommended as second-line treatment for
intrahepatic advanced hepatocellular carcinoma (HCC). However, in Asia, hepatic arterial …
intrahepatic advanced hepatocellular carcinoma (HCC). However, in Asia, hepatic arterial …
[HTML][HTML] The Early Decline of α-Fetoprotein and Des-γ-Carboxy Prothrombin Predicts the Response of Hepatic Arterial Infusion Chemotherapy in Hepatocellular …
S Yamamoto, H Onishi, A Takaki, A Oyama… - Gastrointestinal …, 2020 - ncbi.nlm.nih.gov
Results The number of patients showing a complete response (CR), a partial response (PR),
stable disease (SD), and progressive disease (PD) was 0 (0%), 20 (43%), 18 (38%), and 9 …
stable disease (SD), and progressive disease (PD) was 0 (0%), 20 (43%), 18 (38%), and 9 …
The Early Decline of alpha-Fetoprotein and Des-gamma-Carboxy Prothrombin Predicts the Response of Hepatic Arterial Infusion Chemotherapy in Hepatocellular …
S Yamamoto, H Onishi, A Takaki… - Gastrointestinal …, 2020 - ousar.lib.okayama-u.ac.jp
Introduction: Molecular targeting drugs are recommended as second-line treatment for
intrahepatic advanced hepatocellular carcinoma (HCC). However, in Asia, hepatic arterial …
intrahepatic advanced hepatocellular carcinoma (HCC). However, in Asia, hepatic arterial …